GA
General Atlantic’s Immunocore IMCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,261,684
| Closed | -$37.4M | – | 16 |
|
|
2025
Q1 | $37.4M | Hold |
1,261,684
| – | – | 1.26% | 10 |
|
|
2024
Q4 | $37.2M | Hold |
1,261,684
| – | – | 1.32% | 10 |
|
|
2024
Q3 | $39.3M | Hold |
1,261,684
| – | – | 1.12% | 13 |
|
|
2024
Q2 | $42.8M | Sell |
1,261,684
-245,000
| -16% | -$8.3M | 1.34% | 11 |
|
|
2024
Q1 | $97.9M | Buy |
1,506,684
+556,684
| +59% | +$36.2M | 2.27% | 11 |
|
|
2023
Q4 | $64.9M | Hold |
950,000
| – | – | 0.93% | 13 |
|
|
2023
Q3 | $49.3M | Hold |
950,000
| – | – | 0.76% | 19 |
|
|
2023
Q2 | $57M | Hold |
950,000
| – | – | 0.9% | 17 |
|
|
2023
Q1 | $47M | Hold |
950,000
| – | – | 0.55% | 18 |
|
|
2022
Q4 | $54.2M | Hold |
950,000
| – | – | 0.72% | 18 |
|
|
2022
Q3 | $44.6M | Hold |
950,000
| – | – | 0.53% | 18 |
|
|
2022
Q2 | $35.4M | Hold |
950,000
| – | – | 0.46% | 19 |
|
|
2022
Q1 | $28.4M | Hold |
950,000
| – | – | 0.26% | 22 |
|
|
2021
Q4 | $32.5M | Hold |
950,000
| – | – | 0.25% | 22 |
|
|
2021
Q3 | $35.2M | Hold |
950,000
| – | – | 0.21% | 19 |
|
|
2021
Q2 | $37.1M | Hold |
950,000
| – | – | 0.26% | 13 |
|
|
2021
Q1 | $40.4M | Buy |
+950,000
| New | +$40.4M | 0.47% | 9 |
|